Earnings
Cardinal Health Spinoff Signals New Direction
MATTHEW PERRONE
WASHINGTON (AP) — Drug and medical supplies distributor Cardinal Health will spin off its medical device division this week, streamlining operations after more than a decade of diversified growth, a strategy which analysts say never quite panned out. Beginning Tuesday, Cardinal's medical technology division will begin operating as a separate company called Carefusion, containing nearly two dozen device businesses that were acquired since the mid-1990s. Wall Street analysts have almost unanimously approved of the plan, predicting both companies will report higher earnings after working through initial reorganization. "Fundamentally, distributing pharmaceuticals and medical supplies is a completely different business from developing medical technology," said David Schlotterbeck, newly appointed chief of Carefusion. "We really felt that because these two businesses are so different, they could each thrive more productively on their own." Carefusion's business, which had a fiscal 2009 profit of $448 million, focuses on drug infusion pumps, respiratory equipment and medication dispensing systems. The new company will be headquartered in San Diego. The spinoff marks the end of Cardinal's long-term strategy of using cash from its core business to expand into faster growing health care segments — a strategy that has challenged other competitors in the drug distribution field.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.98
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |


Connect with TheStreet